Novartis Investigative Site

Tualatin, Oregon 97062

0 studies enrolling now · 2 studies all time

What they study most

Pulmonary Arterial Hypertension, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis — Completed
• Extension to QTI571A2301 to Evaluate the Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH) — Stopped early